Wednesday, November 25, 2009, 8:53am EST - Canadian Markets open in 37 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Nektar Therapeutics (NKTR)

On Nov 24: 8.70 USD   0.00 (0.00%)  
MORE ON NKTR
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Fri, Nov 13, 2009
Abbott: Brave or Stupid?
at Motley Fool (Fri, Nov 13)
AstraZeneca Beats, Raises
Zacks.com (Fri, Nov 13)
Tue, Nov 10, 2009
NEKTAR THERAPEUTICS Financials
EDGAR Online Financials (Tue, Nov 10)
Thu, Nov 5, 2009
New Star Analyst Rankings for Nektar Therapeutics
StarMine (Thu, Nov 5)
NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 5)
Wed, Nov 4, 2009
Nektar Therapeutics Financial Results Call scheduled for 5:00 pm ET today
CCBN (Wed, Nov 4)
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
EDGAR Online (Wed, Nov 4)
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
PRNewswire (Wed, Nov 4)
Q3 2009 Nektar Therapeutics Earnings Release - Time Not Supplied
CCBN (Wed, Nov 4)
Thu, Oct 29, 2009
Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
PRNewswire (Thu, Oct 29)
Wed, Oct 28, 2009
Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer
PRNewswire (Wed, Oct 28)
Tue, Oct 27, 2009
Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego New Approach to Treat Opioid-Induced Constipation
PRNewswire (Tue, Oct 27)
Thu, Oct 15, 2009
This Partnership Will Go No Further
at Motley Fool (Thu, Oct 15)
Wed, Oct 14, 2009
Progenics: Investors Are Right To Be Wary
at Seeking Alpha (Wed, Oct 14)
Tue, Oct 13, 2009
NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Tue, Oct 13)
Mon, Oct 12, 2009
Nektar Presents Favorable Data
Zacks.com (Mon, Oct 12)
Sat, Oct 10, 2009
Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in P
PRNewswire (Sat, Oct 10)
Mon, Oct 5, 2009
5 Cold Stocks Heating Up
at Motley Fool (Mon, Oct 5)
Fri, Oct 2, 2009
AstraZeneca: Nektar Deal to Add Value
Zacks.com (Fri, Oct 2)
NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
EDGAR Online (Fri, Oct 2)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices